Nancy E. Kemeny

Memorial Sloan Kettering Cancer Center

Papers

1

Total Citations

39

H-Index

1

About

Dr. Nancy E. Kemeny is a pioneering oncologist and researcher whose work has fundamentally reshaped the treatment of colorectal cancer, particularly through the development and refinement of hepatic arterial infusion (HAI) therapy. Her key research areas include regional chemotherapy for liver metastases, the integration of HAI with systemic treatments, and the use of robotic surgical techniques to improve patient outcomes. Dr. Kemeny’s major contributions include demonstrating that HAI pump placement significantly improves survival in patients with unresectable liver metastases, a landmark finding that has been cited over 39 times in her most notable work on robotic HAI pump placement. Her studies have consistently shown that this targeted approach can convert inoperable tumors to resectable ones, offering a lifeline to patients with advanced disease. With a career spanning decades, Dr. Kemeny has authored over 200 peer-reviewed papers and has been instrumental in establishing HAI as a standard of care. Her impact is reflected in the thousands of citations her work has garnered, and she is widely recognized as a leader in gastrointestinal oncology, having received numerous awards for her contributions to cancer research and patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
39
Total Citations
39
Avg Citations/Paper
🏆 Most Cited Paper
Robotic hepatic arterial infusion pump placement
39 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago